Gradually intensifying, initially barely noticeable symptoms of yellow spot worsening cause difficulties for numerous adult patients. Although the disease primarily affects individuals who have surpassed 50 years of age, it can also occur in the youngest, leading to vision loss and consequently a decrease in overall quality of life.
Yellow spot degeneration
Yellow spot degeneration, commonly referred to as AMD, is a progressive condition that damages the central retinal area. It arises due to: lipid deposit accumulation beneath the retinal pigment epithelium, geographic atrophy of the pigment epithelium, or subretinal neovascularization [3]. Although this condition predominantly affects adult females, its variant – idiopathic polypoidal choroidal vasculopathy – may occur in younger individuals, resulting in visual impairment and, in some cases, complete blindness. Clinically, AMD is classified into two types: dry (non-neovascular) and wet (exudative, neovascular). While the exudative form is less common – affecting only 10–20% of patients – it accounts for 88% of blindness cases.
You have started reading a PRO article
You can preview the first chapter. To read the complete article and unlock all content, upgrade to a PRO account.